Discovery of novel pyrazolo-pyridone DCN1 inhibitors controlling cullin neddylation Journal Article


Authors: Kim, H. S.; Hammill, J. T.; Scott, D. C.; Chen, Y.; Min, J.; Rector, J.; Singh, B.; Schulman, B. A.; Guy, R. K.
Article Title: Discovery of novel pyrazolo-pyridone DCN1 inhibitors controlling cullin neddylation
Abstract: Chemical control of cullin neddylation is attracting increased attention based largely on the successes of the NEDD8-activating enzyme (E1) inhibitor pevonedistat. Recently reported chemical probes enable selective and time-dependent inhibition of downstream members of the neddylation trienzymatic cascade including the co-E3, DCN1. In this work, we report the optimization of a novel class of small molecule inhibitors of the DCN1-UBE2M interaction. Rational X-ray co-structure enabled optimization afforded a 25-fold improvement in potency relative to the initial screening hit. The potency gains are largely attributed to additional hydrophobic interactions mimicking the N-terminal acetyl group that drives binding of UBE2M to DCN1. The compounds inhibit the protein-protein interaction, block NEDD8 transfer in biochemical assays, engage DCN1 in cells, and selectively reduce the steady-state neddylation of Cul1 and Cul3 in two squamous carcinoma cell lines harboring DCN1 amplification. © 2019 American Chemical Society.
Keywords: controlled study; protein expression; unclassified drug; nonhuman; animal cell; steady state; protein protein interaction; protein; protein binding; drug synthesis; structure activity relation; cyclopropane derivative; pyrazole derivative; protein p27; immunoblotting; reactive oxygen metabolite; hydrogen bond; alkylation; pharmacophore; catalysis; protein p21; molecular weight; thin layer chromatography; thermostability; physical chemistry; cyclin e; proton nuclear magnetic resonance; trans isomer; cullin; diastereoisomer; drug solubility; hydrophobicity; neddylation; biochemical analysis; transcription factor nrf2; drug mixture; ligase inhibitor; pyridone derivative; microsome; nedd8 protein; article; metabolic stability; heteronuclear multiple bond correlation; ube2m protein; hcc95 cell line; pevonedistat; 3 methyl n [(3 methyl 6 oxo 1 phenyl 4 (4 tolyl) 4,5,6,7 tetrahydro 1h pyrazolo[3,4 b]pyridin 5 yl]benzamide; 4 (4 fluorobenzylidene) 2 (3 tolyl)oxazol 5(4h) one; defective in cullin neddylation 1; n [4 (4 fluorophenyl) 3 methyl 6 oxo 1 phenyl 4,5,6,7 tetrahydro 1h pyrazolo[3,4 b]pyridin 5 yl] 3 methylbenzamide; n [7 ethyl 4 (4 fluorophenyl) 3 methyl 6 oxo 1 phenyl 4,5,6,7 tetrahydro 1h pyrazolo[3,4 b]pyridin 5 yl] 3 methylbenzamide; cal-33 cell line
Journal Title: Journal of Medicinal Chemistry
Volume: 62
Issue: 18
ISSN: 0022-2623
Publisher: American Chemical Society  
Date Published: 2019-09-26
Start Page: 8429
End Page: 8442
Language: English
DOI: 10.1021/acs.jmedchem.9b00410
PUBMED: 31465221
PROVIDER: scopus
PMCID: PMC7228038
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bhuvanesh Singh
    242 Singh